Bright Minds Applies For Nasdaq Listing
Bright Minds Biosciences (CSE: DRUG) has an eye for the US big boards. The company this morning announced that it
Read more
Bright Minds Biosciences
Psychedelics: The Eight Capital Primer
Eight Capital recently produced a primer on the psychedelic sector saying that the companies are “poised to fill a growing
Read more
Bright Minds Biosciences: Corporate Overview
Bright Minds Biosciences Inc. (CSE: DRUG) is a small-cap preclinical biosciences company that is attempting to create the next generation of
Read more
Bright Minds: The Next Revolution In Mental Health Care – The Daily Dive
Today on the Daily Dive, our host Cassandra Leah sits down with Ian McDonald, CEO of Bright Minds Biosciences (CSE:
Read more
Bright Minds Expands Leadership, Scientific Advisory Teams
Bright Minds Biosciences (CSE: DRUG) this morning enhanced its leadership team. The company appointed two industry executives to key roles
Read more